Dignitana AB (publ) (DIGN.ST)
SEK 0.92
(-2.65%)
SEK 0.92
(-2.65%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 74.73 Million SEK | -2.2% |
| 2022 | 76.41 Million SEK | -8.54% |
| 2021 | 83.55 Million SEK | 0.01% |
| 2020 | 83.55 Million SEK | 24.76% |
| 2019 | 66.97 Million SEK | 24.52% |
| 2018 | 53.78 Million SEK | -10.33% |
| 2017 | 59.98 Million SEK | 48.81% |
| 2016 | 40.3 Million SEK | 105.4% |
| 2015 | 19.62 Million SEK | -0.13% |
| 2014 | 19.64 Million SEK | -4.94% |
| 2013 | 20.67 Million SEK | 26.12% |
| 2012 | 16.39 Million SEK | 229.65% |
| 2011 | 4.97 Million SEK | -77.88% |
| 2010 | 22.47 Million SEK | 113.93% |
| 2009 | 10.5 Million SEK | 31.9% |
| 2008 | 7.96 Million SEK | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 25.89 Million SEK | 198.97% |
| 2024 Q1 | -26.16 Million SEK | -232.7% |
| 2023 Q3 | 18.2 Million SEK | -2.25% |
| 2023 FY | 74.73 Million SEK | -2.2% |
| 2023 Q4 | 19.71 Million SEK | 8.3% |
| 2023 Q1 | 18.18 Million SEK | -42.75% |
| 2023 Q2 | 18.62 Million SEK | 2.41% |
| 2022 Q3 | 15.97 Million SEK | 27.8% |
| 2022 Q4 | 31.76 Million SEK | 98.89% |
| 2022 FY | 76.41 Million SEK | -8.54% |
| 2022 Q1 | 16.17 Million SEK | -42.66% |
| 2022 Q2 | 12.49 Million SEK | -22.75% |
| 2021 Q1 | 15.03 Million SEK | -47.37% |
| 2021 Q3 | 21.55 Million SEK | 14.95% |
| 2021 Q4 | 28.21 Million SEK | 30.91% |
| 2021 FY | 83.55 Million SEK | 0.01% |
| 2021 Q2 | 18.75 Million SEK | 24.7% |
| 2020 FY | 83.55 Million SEK | 24.76% |
| 2020 Q1 | 19.87 Million SEK | -12.93% |
| 2020 Q3 | 16.22 Million SEK | -16.06% |
| 2020 Q4 | 28.57 Million SEK | 76.09% |
| 2020 Q2 | 19.32 Million SEK | -2.75% |
| 2019 Q2 | 15.67 Million SEK | 33.05% |
| 2019 Q1 | 11.78 Million SEK | -5.67% |
| 2019 Q3 | 16.68 Million SEK | 6.41% |
| 2019 Q4 | 22.82 Million SEK | 36.84% |
| 2019 FY | 66.97 Million SEK | 24.52% |
| 2018 Q3 | 14.4 Million SEK | 13.2% |
| 2018 Q1 | 14.17 Million SEK | -23.62% |
| 2018 Q2 | 12.72 Million SEK | -10.21% |
| 2018 Q4 | 12.49 Million SEK | -13.31% |
| 2018 FY | 53.78 Million SEK | -10.33% |
| 2017 FY | 59.98 Million SEK | 48.81% |
| 2017 Q4 | 18.56 Million SEK | 33.57% |
| 2017 Q3 | 13.89 Million SEK | -8.09% |
| 2017 Q2 | 15.11 Million SEK | 21.52% |
| 2017 Q1 | 12.44 Million SEK | -19.75% |
| 2016 Q4 | 15.5 Million SEK | 61.42% |
| 2016 Q3 | 9.6 Million SEK | 9.8% |
| 2016 FY | 40.3 Million SEK | 105.4% |
| 2016 Q1 | 6.46 Million SEK | 14.18% |
| 2016 Q2 | 8.74 Million SEK | 35.35% |
| 2015 Q4 | 5.65 Million SEK | 17.63% |
| 2015 FY | 19.62 Million SEK | -0.13% |
| 2015 Q3 | 4.81 Million SEK | -5.36% |
| 2015 Q2 | 5.08 Million SEK | 24.99% |
| 2015 Q1 | 4.06 Million SEK | -9.53% |
| 2014 Q2 | 5.82 Million SEK | 11.91% |
| 2014 Q1 | 5.2 Million SEK | -11.46% |
| 2014 FY | 19.64 Million SEK | -4.94% |
| 2014 Q4 | 4.49 Million SEK | 8.94% |
| 2014 Q3 | 4.12 Million SEK | -29.12% |
| 2013 Q2 | 5.37 Million SEK | 2.3% |
| 2013 Q1 | 5.25 Million SEK | -5.69% |
| 2013 Q3 | 4.16 Million SEK | -22.56% |
| 2013 Q4 | 5.87 Million SEK | 41.13% |
| 2013 FY | 20.67 Million SEK | 26.12% |
| 2012 FY | 16.39 Million SEK | 229.65% |
| 2012 Q1 | 4.03 Million SEK | 148.61% |
| 2012 Q3 | 3.54 Million SEK | 2.63% |
| 2012 Q4 | 5.57 Million SEK | 57.08% |
| 2012 Q2 | 3.45 Million SEK | -14.39% |
| 2011 Q1 | 4.27 Million SEK | -59.47% |
| 2011 Q2 | -5.82 Million SEK | -236.08% |
| 2011 FY | 4.97 Million SEK | -77.88% |
| 2011 Q4 | -8.3 Million SEK | -320.92% |
| 2011 Q3 | 3.75 Million SEK | 164.6% |
| 2010 Q1 | 3.03 Million SEK | -35.15% |
| 2010 Q2 | 3.89 Million SEK | 28.44% |
| 2010 Q4 | 10.55 Million SEK | 110.96% |
| 2010 Q3 | 5 Million SEK | 28.52% |
| 2010 FY | 22.47 Million SEK | 113.93% |
| 2009 Q4 | 4.67 Million SEK | 131.8% |
| 2009 Q2 | 1.75 Million SEK | -14.98% |
| 2009 FY | 10.5 Million SEK | 31.9% |
| 2009 Q1 | 2.06 Million SEK | 0.0% |
| 2009 Q3 | 2.01 Million SEK | 14.91% |
| 2008 FY | 7.96 Million SEK | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acarix AB (publ) | 82.85 Million SEK | 9.794% |
| ADDvise Group AB (publ) | 611.8 Million SEK | 87.784% |
| ADDvise Group AB (publ) | 611.8 Million SEK | 87.784% |
| Arcoma AB | 53.25 Million SEK | -40.344% |
| Bactiguard Holding AB (publ) | 4.96 Million SEK | -1404.045% |
| BICO Group AB (publ) | 2.84 Billion SEK | 97.376% |
| Boule Diagnostics AB (publ) | 210.44 Million SEK | 64.487% |
| CellaVision AB (publ) | 295.99 Million SEK | 74.75% |
| Clinical Laserthermia Systems AB (publ) | 68.93 Million SEK | -8.423% |
| Chordate Medical Holding AB (publ) | 1.3 Million SEK | -5608.598% |
| C-Rad AB (publ) | 3.8 Million SEK | -1866.737% |
| Duearity AB (publ) | 21.58 Million SEK | -246.24% |
| Episurf Medical AB (publ) | 2.7 Million SEK | -2668.0% |
| Getinge AB (publ) | 10.75 Billion SEK | 99.305% |
| Scandinavian Real Heart AB (Publ) | 18.22 Million SEK | -309.994% |
| Iconovo AB (publ) | 63.35 Million SEK | -17.965% |
| Integrum AB (publ) | 90.57 Million SEK | 17.484% |
| Luxbright AB (publ) | 23.09 Million SEK | -223.665% |
| Mentice AB (publ) | 237.06 Million SEK | 68.474% |
| OssDsign AB (publ) | 175.6 Million SEK | 57.44% |
| Paxman AB (publ) | 133.8 Million SEK | 44.143% |
| Promimic AB (publ) | 48.55 Million SEK | -53.93% |
| Qlife Holding AB (publ) | 162.38 Million SEK | 53.976% |
| SciBase Holding AB (publ) | 69.97 Million SEK | -6.802% |
| ScandiDos AB (publ) | 61.03 Million SEK | -22.442% |
| Sectra AB (publ) | 39.06 Million SEK | -91.322% |
| Sedana Medical AB (publ) | 174.52 Million SEK | 57.178% |
| Senzime AB (publ) | 141.51 Million SEK | 47.189% |
| SpectraCure AB (publ) | 12.12 Million SEK | -516.227% |
| Stille AB | 87.21 Million SEK | 14.312% |
| Vitrolife AB (publ) | 5.56 Billion SEK | 98.658% |
| Xvivo Perfusion AB (publ) | 440.92 Million SEK | 83.05% |